Join us for the next #BHHSeries virtual event on Wednesday May 13 at 5pm to learn more about Digital Therapeutics: Expanding Access to Healthcare?
Digital Therapeutics (DTx) refer to softwares or apps that can replace or complement traditional therapies or drugs. They are clinically validated and regulated, and can be used from anywhere 24/7. DTx have emerged as a great companion for patients and an attractive solution for pharma companies to complement their products and to target diseases with no know therapies.
In this session, we will discuss the recent developments around DTx, what role they will play in the healthcare systems in the coming months and what entrepreneurs looking at developing digital therapeutics should take into account.
We will talk with Lina Behrens, Managing Director at Flying Health, David Martín-Corral, CEO and Co-Founder at Zensei, Guillem Masferrer, Associate at Asabys Partners and Celine Ulmann, Head of R&D Digital at Almirall.
We hope to see you this Wednesday May 13 at 5pm here!